CKD-mineral and bone disorder: core curriculum 2011.
Department of Medicine, Indiana University, School of Medicine, Indianapolis, IN 46202, USA. rmoorthi@iupui.edu
Ranjani N
RN
Moorthi
Sharon M
SM
Moe
D001847:Bone Diseases / Q000150:complications* / Q000503:physiopathology*; D002114:Calcinosis; D002115:Calciphylaxis / Q000503:physiopathology; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000097:blood; D002614:Chelating Agents / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000503:physiopathology; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000502:physiology; D006801:Humans; D054559:Hyperphosphatemia / Q000503:physiopathology / Q000517:prevention & control; D007668:Kidney / Q000473:pathology / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D007684:Kidney Tubules / Q000503:physiopathology; D007811:Lanthanum / Q000627:therapeutic use; D010281:Parathyroid Hormone / Q000097:blood / Q000502:physiology; D016105:Parathyroidectomy; D010758:Phosphorus / Q000097:blood / Q000502:physiology; D011073:Polyamines / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D000069603:Sevelamer; D014807:Vitamin D / Q000502:physiology
D002614:Chelating Agents; D010281:Parathyroid Hormone; D011073:Polyamines; D014807:Vitamin D; D010758:Phosphorus; C119467:lanthanum carbonate; D005346:Fibroblast Growth Factors; D007811:Lanthanum; D000089703:Fibroblast Growth Factor-23; D000069603:Sevelamer; D002117:Calcitriol; D002118:Calcium